Skip to content

Clear Labels Act

On calendar: it can still change before the session ends.

US S 3788 · Senate Bill · 119th Congress

Stage
On calendar
Started in
Senate
Sponsors
13
Latest action
Jul 27, 2026

What it does

Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act or the CLEAR LABELS Act This bill requires drugs and active pharmaceutical ingredients made available in the U.S. market to be labeled with the names and locations of their manufacturers. Specifically, a finished, packaged drug product must be labeled with the name and place of business of (1) the original manufacturer (or manufacturers) of each active pharmaceutical ingredient; (2) the original manufacturer of the finished drug product; and (3) the packer or distributor, if any. This information must be printed on the product label or made available electronically. Active pharmaceutical…

Official summary · Reported to Senate · Jul 27, 2026

Titles and provisions can change as the bill moves.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Feb 5, 2026

  2. Committee (Current step)

    On calendar · Jul 27, 2026

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

CLEAR LABELS Act | 52